The estimated Net Worth of Marga Ortigas Wedekind is at least 2.08 百万$ dollars as of 11 November 2021. Marga Wedekind owns over 9,000 units of Omnicell stock worth over 724,610$ and over the last 16 years Marga sold OMCL stock worth over 1,353,052$.
Marga has made over 51 trades of the Omnicell stock since 2010, according to the Form 4 filled with the SEC. Most recently Marga bought 9,000 units of OMCL stock worth 53,910$ on 11 November 2021.
The largest trade Marga's ever made was selling 28,369 units of Omnicell stock on 10 March 2014 worth over 817,595$. On average, Marga trades about 2,030 units every 66 days since 2009. As of 11 November 2021 Marga still owns at least 16,824 units of Omnicell stock.
You can see the complete history of Marga Wedekind stock trades at the bottom of the page.
Marga's mailing address filed with the SEC is 2118 WALSH AVE, SUITE 210, , SANTA CLARA, CA, 95050.
Over the last 21 years, insiders at Omnicell have traded over 118,258,750$ worth of Omnicell stock and bought 526,030 units worth 5,215,749$ . The most active insiders traders include William H Jr Younger、Randall A Lipps、Benjamin A Horowitz. On average, Omnicell executives and independent directors trade stock every 10 days with the average trade being worth of 482,255$. The most recent stock trade was executed by Christine Marie Mellon on 9 June 2023, trading 7,951 units of OMCL stock currently worth 581,536$.
since 1992, omnicell has been creating new efficiencies to improve patient care, anywhere it is delivered. omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. omnicell’s automated hardware/software systems for medication dispensing include solutions from the point of entry into the hospital through the central pharmacy, nursing unit, operating room, and patient bedside. our supply management systems promote greater cost control and charge capture for payer reimbursement, and improve management and reordering of inventory. omnicell® products range from high-security, closed-cabinet systems and software to open-shelf and combination systems in the nursing unit, cath lab, and operating room. more than 3,200 customers worldwide have utilized omnice
Omnicell executives and other stock owners filed with the SEC include: